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OBJECTIVES This study evaluated the acute physiological gain of adjunctive intravascular ultrasound
(IVUS) guided balloon angioplasty and stent implantation.
BACKGROUND Recent studies indicate safe coronary luminal enlargement and “stent-like” long-term
outcomes using upsized balloons guided by IVUS.
METHODS After angiographically guided balloon angioplasty in 20 patients with 1-vessel disease and
normal left ventricular function, IVUS was performed to determine the size of the adjunctive
balloon using the mean of the maximal luminal diameter and the maximal diameter of the
external elastic membrane measured in the adjacent proximal and distal reference segments.
Serial adenosine-induced hyperemic blood flow velocity measurements were performed using
a 0.014" Doppler guide wire to determine the physiological lumen obstruction after standard
balloon angioplasty, followed by IVUS-guided balloon angioplasty and stent implantation.
RESULTS Upsized balloon angioplasty (increase balloon size: 0.98 6 0.26 mm; balloon:artery ratio
1.35 6 0.21) resulted in an additional increase of arterial dimensions: minimal lumen
diameter (MLD) 2.18 6 0.38 mm to 2.73 6 0.51 mm; percent diameter stenosis (%DS)
34 6 13% to 19 6 22%; IVUS assessed minimal lumen area (MLA) 7.53 6 1.55 mm2 to
10.24 6 2.22 mm2 (all p , 0.0001). Major dissections ($ type C) did not occur. Hyperemic
blood flow velocity increased from 49.8 6 20.1 cm/s to 59.1 6 22.9 cm/s (p , 0.05) after
IVUS-guided balloon angioplasty. Adjunctive stent implantation resulted in a further increase
of MLD to 3.84 6 0.51 mm, %DS to 29 6 21% and MLA to 13.39 6 1.80 mm2 (all
p , 0.0001), while hyperemic blood flow velocity remained unchanged (61.2 6 24.7 cm/s,
p 5 0.7).
CONCLUSIONS Upsized IVUS-guided balloon angioplasty increases arterial coronary dimensions and the
distal hyperemic blood flow velocity. Adjunctive stent implantation does not yield a further
gain in the hyperemic blood flow velocity, indicating the absence of a functional residual
lumen obstruction after IVUS-guided balloon angioplasty. This may explain a similar clinical
outcome reported after those coronary interventions. (J Am Coll Cardiol 1999;34:1899–906)
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The high incidence of restenosis remains a major drawback
of balloon coronary angioplasty. Several studies described a
better long-term clinical or angiographic outcome following
an optimal postprocedural result (1–3). Several alternative
treatment modalities have been evaluated in order to opti-
mize the initial angiographic success, i.e., directional
atherectomy (4,5), coronary stent implantation (6–8) and
intravascular ultrasound (IVUS) guided stent implantation
(9). These studies involving atherectomy and coronary stent
implantation confirmed earlier reports that an optimal, i.e.
larger, procedural result is relevant for both angiographic
and clinical long-term outcome (4–8). Several IVUS studies
documented the presence of coronary atherosclerosis with
compensatory lumen enlargement in the adjacent angiographi-
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cally normal reference artery segments (10–12). This novel
insight into the dynamic atherosclerotic process resulted in the
evaluation of IVUS-guided balloon angioplasty with balloons
otherwise considered to be oversized. Recent studies have
indicated that the use of upsized balloons guided by IVUS is
safe and results in a similar long-term angiographic and clinical
outcome as reported after stent implantation (13,14).
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The usefulness of coronary angiography in assessing
residual lumen obstruction after coronary angioplasty is
limited (15). A recently published multicenter study, Dopp-
ler End points Balloon Angioplasty Trial Europe
(DEBATE), indicated the additional value of a physiolog-
ical parameter, i.e. distal intracoronary blood flow velocity
reserve (CFVR), in the evaluation of the postprocedural
angiographic result (16). In spite of its clinical relevance,
only a limited number of studies have been performed
concerning the relationship between the arterial dimensions
and physiological responses following adjunctive stent im-
plantation (17,18). In conjunction, these studies underlined
the importance of optimizing the angiographic result and
physiological status following standard balloon angioplasty.
However, postprocedural measurements of CFVR are sensitive
to temporary baseline blood flow velocity fluctuations (19–21),
indicating that hyperemic blood flow velocity is potentially a
better physiological variable for the evaluation of residual
lumen obstruction following coronary interventions.
Consequently, the purpose of this study was to determine
the physiological gain after standard balloon angioplasty and
adjunctive IVUS-guided balloon angioplasty and stent im-
plantation by serial measurements of distal hyperemic blood
flow velocity.
METHODS
Patients. Patients with de novo or restenotic single vessel
disease of native coronary arteries and normal left ventric-
ular function referred to our institution for elective stent-
implantation (n 5 20) were studied prospectively. Inclusion
criteria were:
1) angina pectoris refractory to medical therapy,
2) proximal coronary lesion suitable for stent implantation.
Exclusion criteria were:
1) multilesion one-vessel disease,
2) functional or total coronary occlusion,
3) previous cardiac surgery,
4) electrocardiographic evidence of left ventricular hyper-
trophy or conduction abnormalities,
5) previous Q-wave myocardial infarction, and
6) non–Q-wave myocardial infarction less than one week
before PTCA.
The protocol was approved by the Institutional Ethics
Committee and all patients gave written informed consent.
Cardiac catheterization. Therapy with all antianginal
medication was continued until cardiac catheterization. All
patients received aspirin (100 mg) administered orally the
night before percutaneous transluminal coronary angio-
plasty (PTCA). Lorazepam (1 mg) was orally administered
before the procedure. Cardiac catheterization was per-
formed in all patients by the percutaneous femoral ap-
proach. All patients received unfractionated heparin
(7,500 IU) intravenously as a bolus at the beginning of the
procedure. Additional heparin was administered if the
procedure lasted more than 90 min. Nitroglycerin (0.1 mg
intracoronary) was administered before quantitative coro-
nary angiography (QCA) and every 30 min throughout the
procedure. Consecutive balloon inflations of 1–2 min dura-
tion were performed until an angiographically satisfactory
result as determined by the consensus of two experienced
operators was obtained after an additional waiting time of
10 min. Single coronary stents (Palmaz-Schatz, Johnson &
Johnson, Warren, New Jersey) were deployed using high
balloon inflation pressures (14 6 3 atm).
Quantitative coronary angiography. Off-line analysis of
the angiographic severity of the coronary narrowing was
performed using an automated contour detection algorithm
(QCA-CMS Version 3.32, MEDIS, Leiden, the Nether-
lands) (22). The outer diameter of the centered, fluid-filled
guiding catheter was used as a calibration device to obtain
absolute arterial dimensions. Two orthogonal projections of
the coronary artery lesion during the end-diastolic phase
were used to assess biplane analysis of the minimal lumen
diameter (MLD), minimal lumen area (MLA), percent
diameter stenosis (%DS) and percent area stenosis (%AS) of
the coronary narrowing. On-line QCA analysis was per-
formed to determine the balloon size for standard balloon
angioplasty. Quantitative coronary angiography was per-
formed in the same projections before and after standard
balloon angioplasty, IVUS-guided balloon angioplasty and
stent implantation. Quantitative coronary angiography after
high-pressure stent implantation was performed according
to the method described by Reimers et al., excluding the
stented segment from the calculation of the reference
diameter (23). The nominal balloon:artery ratio was defined
as the ratio between the nominal balloon size according to
the inflation pressure used and the QCA-measured inter-
polated reference diameter at the site of the MLD. The
QCA balloon:artery ratio was defined as the ratio between
the QCA-measured size of the balloon and the QCA-
measured reference diameter. Angiographic grading of cor-
Abbreviations and Acronyms
ANOVA 5 analysis of variance
%AS 5 percent area stenosis
CFVR 5 distal coronary flow velocity reserve
CLOUT 5 Clinical Outcomes with Ultrasound Trial
DEBATE 5 Doppler End points Balloon Angioplasty
Trial Europe
%DS 5 percent diameter stenosis
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MLA 5 minimal lumen area
MLD 5 minimal lumen diameter
PTCA 5 percutaneous transluminal coronary
angioplasty
QCA 5 quantitative coronary angiography
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onary dissections was performed according to the criteria of
the National Heart, Lung, and Blood Institute Percutane-
ous Transluminal Coronary Angioplasty Registry (24).
Intravascular ultrasound analysis. Intravascular imaging
was performed using a 2.9F monorail system with a
30 MHz mechanically rotating ultrasound transducer (Car-
dioVascular Imaging Systems, Inc., Sunnyvale, California).
After standard balloon angioplasty, the imaging catheter
was positioned distal to the dilated segment and ultrasound
gain was adjusted to allow maximal gray scale differentia-
tion. Images were recorded continuously on a VHS-tape
during manual pull-back of the transducer. After an intra-
vascular ultrasound study was completed, the videotape was
reviewed to determine the optimal reference sites. Measure-
ments were taken from both the proximal and distal
reference segment. A proximal or distal segment alone was
used as a reference segment in the case of a lesion adjacent
to a bifurcation. The maximal diameters of the reference
lumen and vessel (the external elastic membrane) were
measured. The size of the upsized balloon was determined
by using the following equation employing measurements
from either the proximal or distal reference site: balloon
size 5 (maximal lumen diameter 1 maximal vessel diame-
ter)/2.
Intravascular ultrasound was performed after stent im-
plantation to evaluate optimal stent deployment, i.e. circular
deployment of the stent and avoidance of echo-free spaces
between the stent and the inner vascular wall. Off-line
IVUS analysis was performed to determine the MLD,
MLA (Fig. 1), the area of the external elastic membrane
(vessel area) and the percentage plaque area (vessel area
minus MLA) after each intervention. The intraobserver and
interobserver variability of the aforementioned IVUS vari-
ables at our center were reported previously (25).
Coronary blood flow analysis. All coronary blood flow
velocity measurements with the Doppler angioplasty guide
wire (FloWire, EndoSonics, Rancho Cordova, California)
were performed as previously described (26,27). The tip of
the Doppler guide wire was placed distal to the stenosis and
manipulated until an optimal and stable blood flow velocity
Figure 1. This representative patient demonstrates a luminal enlargement after standard balloon angioplasty, after IVUS-guided balloon
angioplasty and after stent implantation in single frame angiograms and IVUS images of the proximal LAD. However, the coronary flow
reserve (ratio) remains impaired after each intervention (1.9, 1.9 and 1.5, respectively) as a result of the increased baseline blood flow
velocity (BAPV) (26, 37 and 45 cm/s, respectively). Therefore, hyperemic blood flow velocity (PAPV) was used to assess the functional
improvement after each intervention (49, 69 and 67 cm/s). In this patient, the maximal functional gain was accomplished after
IVUS-guided balloon angioplasty as there was no additional increase in hyperemic blood flow after stent implantation. Note: baseline and
hyperemic flow velocity signals are depicted on different y-axis scales during the procedure. IVUS 5 intravascular ultrasound; LAD 5 left
anterior descending coronary artery; MLA 5 minimal lumen area.
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signal was obtained. After on-line assessment of the baseline
average peak velocity, hyperemia was induced by the ad-
ministration of an intracoronary bolus of adenosine (12 mg
in the right coronary artery; 18 mg in the left coronary
artery). Pressure recording through the guiding catheter was
carefully monitored to exclude signs of obstruction of flow
during hyperemia. Distal coronary flow velocity reserve was
defined as the ratio of the maximal hyperemic/baseline
average peak velocity. These blood flow velocity measure-
ments were performed at the same location after each
intervention (Fig. 1). The reference CFVR was determined
in an adjacent, angiographically normal coronary artery after
completion of the procedure. The relative CFVR (rCFVR)
was defined as the ratio of the distal/reference CFVR.
Statistical analysis. Continuous variables are presented as
mean 6 SD. Chi-square analysis was used for comparison
of the different types of coronary dissections after standard
balloon angioplasty and IVUS-guided balloon angioplasty.
Analysis of variance (ANOVA) for ordered groups (consid-
ering a significant linear trend) was used to compare
continuous data between the subsequent interventions, i.e.
before balloon angioplasty, after balloon angioplasty, after
IVUS-guided balloon angioplasty and after stent implanta-
tion. A two-tailed paired t test (or Wilcoxon test for
nonparametric data) was used to identify differences be-
tween blood flow velocity variables or geometric dimensions
of the dilated coronary artery after the subsequent types of
intervention, in specific after IVUS-guided balloon angio-
plasty and stent implantation. Statistical analysis was per-
formed with SSPS (SPSS Inc., Chicago, Illinois) software
for Macintosh, version 6.1.1. A p value ,0.05 was consid-
ered statistically significant.
RESULTS
Patients. Baseline characteristics of the patients studied
(mean age 54 6 11 years, range 36–73 yr) are depicted in
Table 1. Ten patients were treated for a de novo lesion and
10 patients for a restenotic lesion. All patients underwent
elective stent implantation for a proximal lesion using a
15 mm (n 5 15) or an 18 mm (n 5 5) Palmaz-Schatz stent.
All procedures were successfully completed without isch-
emic complications.
Quantitative coronary angiographic and intravascular
ultrasound data. The mean angiographic reference diam-
eter before balloon angioplasty was 3.37 6 0.62 mm.
Standard balloon angioplasty (nominal balloon:artery ra-
tio 5 1.07 6 0.15) improved the MLD from 1.05 6
0.39 mm to 2.18 6 0.38 mm and the %DS from 68 6 13%
to 34 6 13% (both p , 0.0001, Table 2).
Intravascular ultrasound analysis after standard balloon
angioplasty of the reference segment showed an MLD of
4.3 6 0.5 mm and a maximal vessel diameter of 4.9 6
0.4 mm (mean diameter: 4.58 6 0.36 mm, MLA: 12.7 6
1.9 mm2, percent plaque: 13 6 12%). The balloons were
upsized by 0.98 6 0.26 mm (range 0.53–1.50 mm, p ,
0.0001) to a nominal diameter of 4.41 6 0.28 mm. This
resulted in an increased nominal and QCA-measured bal-
loon:artery ratio (Table 2). Quantitative coronary angiogra-
phy and IVUS showed an increase in luminal dimensions
after IVUS-guided balloon angioplasty (Tables 2 and 3).
Adjunctive stent deployment was successful in all patients
according to the IVUS criteria. Stent implantation resulted
in a further increase in luminal dimensions (Tables 2 and 3).
All continuous data showed a significant trend across the
subsequent types of intervention.
Blood flow velocity data. Heart rate and mean aortic
pressure did not differ between the serial blood flow velocity
measurements (Table 4). The CFVR increased after stan-
dard balloon angioplasty from 1.5 6 0.6 to 2.6 6 0.7
towards the CFVR measured in the normal adjacent coro-
nary artery (3.2 6 0.7, rCFVR: 0.83 6 0.22), despite an
increase from 12 6 5 cm/s to 22 6 10 cm/s (p , 0.0001,
Table 4) in baseline blood flow velocity. Adjunctive IVUS-
guided balloon angioplasty resulted in a further increase in
hyperemic blood flow velocity (Table 4), while a nonsignif-
icant increase of baseline blood flow velocity precluded a
further increase in CFVR and rCFVR (Table 4, Fig. 1). All
blood flow velocity variables did not reveal changes after
Table 1. Baseline Characteristics of the Study Patients
Characteristic n 5 20 Patients
Age (yrs) 54 6 11 (range 36–73)
Male 17 (85%)
Functional class CCS:
II 3 (15%)
III 13 (65%)
IV 4 (20%)
Systemic hypertension 7 (35%)
Cigarette smoking 11 (55%)
Total cholesterol .6.5 mmol/l 8 (40%)
Diabetes mellitus 1 (5%)
Family history 5 (25%)
Previous myocardial infarction 6 (30%)
Medication:
beta-blocker 19 (95%)
nitrate 10 (50%)
calcium-antagonist 13 (65%)
ace-inhibitor 2 (10%)
Coronary artery dilated:
LAD 11 (55%)
RCA 5 (25%)
LCx 4 (20%)
Lesion type (ACC/AHA):
A 1 (5%)
B1 10 (50%)
B2 7 (35%)
C 2 (10%)
ACC/AHA 5 American College of Cardiology/American Heart Association;
CCS 5 Canadian Cardiovascular Society; LAD 5 left anterior descending coronary
artery; RCA 5 right coronary artery; LCx 5 left circumflex coronary artery.
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stent implantation (Table 4). Furthermore, the hyperemic
coronary blood flow velocity responses of patients using
calcium antagonists did not differ from those not using
calcium antagonists before PTCA (19 6 9 cm/s vs. 15 6 9
cm/s; p 5 0.40), after standard balloon angioplasty (53 6 19
cm/s vs. 44 6 22 cm/s; p 5 0.37), after IVUS-guided
balloon angioplasty (62 6 25 cm/s vs. 54 6 20 cm/s; p 5
0.48) and after stent implantation (65 6 28 cm/s vs. 55 6
19 cm/s; p 5 0.41). All continuous data (with exception of
heart rate and mean aortic pressure) showed a significant
trend across the subsequent types of intervention.
Coronary dissections. Angiography of the treated coro-
nary artery immediately after standard balloon angioplasty
revealed type A coronary dissections in 3/20 patients and
type B dissections in 7/20 patients. A nonsignificant in-
crease in type A dissections was noted after IVUS-guided
balloon angioplasty (type A in six patients, type B in eight
patients, x2 5 2.07; p 5 0.36). The number of coronary
dissections decreased by stent implantation; three type B
dissections and one type C dissection were noticed in an
adjacent segment after stent implantation (x2 5 13.8; p ,
0.01).
The hyperemic blood flow velocity measurements of
patients without coronary dissections did not differ from
those patients with coronary dissections after standard
balloon angioplasty (51.2 6 25.3 cm/s vs. 48.3 6 14.3 cm/s,
p 5 0.76) or after IVUS-guided balloon angioplasty (58.7 6
22.2 cm/s vs. 59.2 6 24.0 cm/s, p 5 0.96).
DISCUSSION
This study demonstrates for the first time that adjunctive
IVUS-guided balloon angioplasty induces an additional
increase in hyperemic blood flow velocity related to a
reduction of residual lumen obstruction. Subsequent stent
implantation resulted in a further increase of coronary
luminal dimensions while the hyperemic blood flow velocity
parameters remained unchanged, indicating the absence of a
functional residual lumen obstruction after IVUS-guided
balloon angioplasty. Furthermore, this study confirms an
earlier report showing that IVUS facilitates the safe use of
balloons traditionally considered oversized with respect to
the occurrence of coronary dissections (13).
Coronary lumen enlargement after IVUS-guided balloon
angioplasty and stent implantation. Successful conven-
tional balloon angioplasty results in a 30%–50% residual
lumen obstruction immediately after the procedure. Several
studies reported better long-term angiographical and clini-
cal outcomes as a result of lower residual lumen obstructions
after PTCA (,30 %DS) (1–3). However, the use of
oversized balloons was complicated by the frequent occur-
rence of dissections and ischemic complications after PTCA
(28,29). Roubin et al. (28) demonstrated that the size of the
balloon was an independent predictor for emergency bypass
graft surgery as larger balloons (nominal balloon:artery
ratio 5 1.13 6 0.14) increased the rate of severe dissections.
Consequently, several alternative angioplasty techniques
Table 2. Quantitative Coronary Angiography Variables in 20 Patients Before and After Standard Balloon Angioplasty, After IVUS-
Guided Balloon Angioplasty and After Stent Implantation
Before BA After Standard BA After IVUS-Guided BA After Stent-Implantation
MLD (mm) 1.05 6 0.39 2.18 6 0.38* 2.73 6 0.52* 3.84 6 0.51*
MLA (mm2) 0.95 6 0.61 3.91 6 1.35* 6.43 6 2.67* 11.82 6 2.91*
%DS 68 6 13 34 6 13* 19 6 22* 29 6 21*
%AS 88 6 7 55 6 15* 30 6 46* 222 6 48*
Nominal B:A ratio – 1.07 6 0.14 1.35 6 0.21* 1.40 6 0.21
QCA B:A ratio – 0.97 6 0.14 1.22 6 0.22* 1.29 6 0.24
Gain (mm) – 1.13 6 0.43 1.69 6 0.60* 2.79 6 0.61*
Acute recoil (mm) – 0.98 6 0.47 1.24 6 0.59 0.52 6 0.65*
*p , 0.05 compared with the paired values of the previous measurement.
%AS 5 percent area stenosis; BA 5 balloon angioplasty; B:A ratio 5 balloon size/coronary artery size ratio; %DS 5 percent diameter stenosis; IVUS 5 intravascular
ultrasound; MLA 5 minimal lumen area; MLD 5 minimal lumen diameter; QCA 5 quantitative coronary angiography.
Table 3. Intravascular Ultrasound Variables After Standard Balloon Angioplasty, After IVUS-Guided
Balloon Angioplasty and After Stent Implantation
After standard BA
(n 5 19)
After IVUS-guided BA
(n 5 18)
After Stent-Implantation
(n 5 18)
MLD (mm) 2.93 6 0.48 3.11 6 0.54* 3.93 6 0.29*
MLA (mm2) 7.53 6 1.55 10.24 6 2.22* 13.39 6 1.80*
EEM area (mm2) 21.75 6 6.04 22.93 6 4.40 23.72 6 4.98
MLA/reference LA 0.61 6 0.15 0.86 6 0.28* 1.09 6 0.19*
% plaque area 63 6 12 53 6 13* 42 6 12*
*p , 0.05 compared with the paired values of the previous measurement.
EEM 5 external elastic membrane; reference LA 5 lumen area of the reference segment. Other abbreviations as in Table 2.
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(i.e. directional atherectomy, coronary stent implantation)
were employed in order to obtain a larger sized lumen
directly after PTCA without the occurrence of severe
coronary complications (4–8). Two recently published
studies by Stone et al. [Clinical Outcomes with Ultrasound
Trial (CLOUT) pilot study] (13) and Haase et al. (14)
demonstrated the safe use of upsized balloons when guided
by IVUS. Furthermore, Haase et al. demonstrated “stent-
like” long-term angiographical and clinical outcomes after
IVUS-guided balloon angioplasty (14). This principle was
based on the presence of compensatory vessel enlargement
at the site of the lesion to preserve a larger lumen, the
so-called “Glagov phenomenon” (11,12). The extension of
atherosclerosis and compensatory vessel enlargement to the
reference segment may result in an angiographical underes-
timation of the true size of the reference segment (10). In
the forementioned IVUS-guided balloon angioplasty stud-
ies, different strategies were used to determine the optimal
balloon size, resulting in different balloon:artery ratios of
1.30 6 0.17 (13) and 1.38 6 0.25 (14). The CLOUT pilot
study reported a reduction of residual lumen obstruction
from 28 6 15 to 18 6 14 %DS without an increase in the
incidence of coronary dissections as determined by angiog-
raphy. In this study, balloons were upsized using the average
of the maximal vessel diameter and the maximal lumen
diameter of the adjacent reference segments assessed by
IVUS analysis. This resulted in a slightly larger balloon:
artery ratio of 1.35 6 0.21 as compared with the CLOUT
pilot trial. Nevertheless, the lumen enlargement after IVUS-
guided balloon angioplasty (19 6 22 %DS) was similar to
the results of the CLOUT trial. These angiographic results
after IVUS-guided balloon angioplasty are in accordance
with angiographic studies after adjunctive stent implanta-
tion using conventional balloon pressures of ;10 atm
(6–8). However, the use of higher balloon pressures
(15 atm) for in stent balloon inflations produced less
residual lumen obstruction (1 6 9 %DS) (9). Colombo et al.
described an even more pronounced lumen enlargement (to
29 6 15 %DS) after stent implantation using oversized
balloons with high-pressure inflation. These results were
similar to the angiographic results of this study immediately
after IVUS-guided stent implantation.
This study did not demonstrate an increase in coronary
dissections after IVUS-guided balloon angioplasty, taken
into account the limited number of patients studied. These
findings are in accordance with the studies of Haase et al.
and Stone et al., indicating the safe use of IVUS-guided
balloon angioplasty.
Hemodynamic response after IVUS-guided balloon an-
gioplasty and coronary stent implantation. Several stud-
ies, including this study, showed a normalization of the
CFVR (.2.5) after standard balloon angioplasty (16,30).
However, there are a limited number of studies evaluating
balloon angioplasty and adjunctive coronary interventions in
relation to coronary hemodynamics (17,18). A reduced or
nearly normal coronary flow reserve after balloon angio-
plasty may improve towards the value of the reference
coronary flow reserve of the normal adjacent coronary artery
after coronary stent implantation (17,18). The results of a
recently published multicenter study (DEBATE) have
demonstrated the prognostic value of an optimal angio-
graphic result (DS , 35%) in conjunction with a normal-
ization of CFVR (.2.5) after balloon angioplasty (16). The
aforementioned angiographic studies supporting the con-
cept “the bigger, the better,” as well as the DEBATE-study,
underline the clinical relevance of optimizing the procedural
result. This study indicates that IVUS-guided balloon
angioplasty following balloon angioplasty results in an
optimal procedural, angiographical and hemodynamic out-
come. The alterations in coronary hemodynamics in relation
to residual lumen obstruction were evaluated by the hyper-
emic blood flow velocity values. In a recent study we
demonstrated two different baseline flow velocity responses
following balloon angioplasty or stent implantation. A
normalized CFVR was associated with a normal baseline
flow velocity following intervention, while an impaired
CFVR (,2.5) was associated with an increase in baseline
blood flow velocity, which may be caused by a temporary
loss of the microvascular autoregulation (21). In this study,
the hyperemic blood flow velocity increased after standard
balloon angioplasty and subsequent IVUS-guided balloon
angioplasty. The study of Haase et al. demonstrated a
clinical outcome following IVUS-guided balloon angio-
Table 4. Hemodynamic and Distal Blood Flow Velocity Variables Measured Before and After Standard Balloon Angioplasty, After
IVUS-Guided Balloon Angioplasty and After Stent Implantation in All Patients
Before BA After Standard BA After IVUS-Guided BA After Stent-Implantation
HR (beats/min) 62.4 6 10.1 61.4 6 9.9 61.9 6 8.9 63.1 6 10.3
MAP (mm Hg) 85.3 6 7.2 85.1 6 8.7 86.0 6 9.9 86.0 6 12.0
Base-APV (cm/s) 11.8 6 5.5 21.6 6 9.7* 24.8 6 13.7 25.6 6 15.9
Hyp-APV (cm/s) 17.4 6 9.2 49.8 6 20.1* 59.1 6 22.9* 61.2 6 24.7
CFVR 1.51 6 0.60 2.63 6 0.69* 2.69 6 0.80 2.81 6 1.10
rCFVR 0.48 6 0.18 0.83 6 0.22* 0.87 6 0.23 0.88 6 0.26
*p , 0.05 compared with the paired values of the previous measurement.
Base-APV 5 baseline average peak velocity; CFVR 5 coronary blood flow velocity reserve; HR 5 heart rate; Hyp-APV 5 hyperemic average peak velocity; MAP 5 mean
aortic pressure; rCFVR 5 relative coronary blood flow velocity reserve. Other abbreviations as in Table 2.
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plasty similar to the reported results after stent implantation
(14). This study demonstrates that adjunctive stent implan-
tation does not yield a further gain in the hyperemic blood
flow velocity, indicating the absence of a functional residual
lumen obstruction after IVUS-guided balloon angioplasty,
which may explain a similar long-term clinical outcome
following IVUS-guided balloon angioplasty as compared
with stent implantation. Furthermore, the present results
are in accordance with experimental data in the classic study
of Gould et al. (31), describing a curvilinear relationship
between the severity of short-term artificial coronary lesions
and hyperemic blood flow in healthy sedated dogs, i.e., a
plateau phase of hyperemic flow in coronary residual lumen
obstructions ,30 %DS.
Study limitations. These results were obtained from a
small uniform selected group of patients with one-vessel
disease and large reference diameters (i.e. 3.37 6 0.62 mm),
which limits the extrapolation of the present findings to
other patient categories. The relative large reference diam-
eter as well as the initial results after balloon angioplasty
may be responsible for the differences between other studies
showing an increase in coronary flow reserve after adjunctive
stent implantation (17,18).
A limitation of this study is the lack of intracoronary
pressure measurements. The pressure gradient or corre-
sponding fractional flow reserve across the treated lesion
may be used as another physiological variable for the
residual lumen obstruction after different treatment modal-
ities. A recent study suggests that the assessment of the
pressure gradient by means of a guide wire may serve as an
alternative for IVUS to optimize stent implantation (32).
The complexity of the present protocol precluded additional
pressure measurements in our study. Furthermore, blood
flow velocity alterations may not be interpreted as changes
due to fluctuations in the diameter of the epicardial coronary
segment as a result of alpha-mediated vasoconstriction
induced by mechanical stretch and hypoperfusion during
balloon inflation (33,34). Nitroglycerin (intracoronary) was
administered throughout the procedure in order to mini-
mize this confounding factor.
The site of the repeated blood flow velocity measure-
ments was determined by angiography, although this
method for making repeated measurements may have been
a contributing factor in the variations noted.
Hyperemic blood flow velocity is subject to an interpa-
tient variability related to a variety of physiologic (35–37)
and pathophysiologic conditions of epicardial conduits or
the distal microvascular bed (38–41). These confounding
factors were limited by the inclusion criteria and, again, by
serial observations in individual patients. However, the
various interventional techniques used may induce different
degrees of medial injury resulting in different grades of
platelet activation, microembolization of platelet aggregates,
and the release of platelet-mediated vasomotor products
may influence hyperemic flow (42). Nevertheless, each
patient received aspirin before the procedure, limiting plate-
let aggregation. Furthermore, there was no variability in
hyperemic blood flow velocity between those patients with
and those without coronary dissections, which suggests that
the effect of this potential factor was limited. Moreover,
even if stent implantation may not add any acute advantage
in terms of distal perfusion following optimal IVUS-guided
PTCA, this aspect does not take into consideration sub-
acute recoil, next day lumen loss and chronic remodelling.
This study was not designed to measure subacute recoil after
the different types of interventions and therefore did not allow
the exclusion of the possibility of an additional protective role
of stenting despite IVUS-guided balloon angioplasty.
Clinical implications. Intravascular ultrasound guided bal-
loon angioplasty safely provided a direct lumen enlargement
and increase in hyperemic blood flow velocity as compared
with standard balloon angioplasty. Despite additional lumen
enlargement, adjunctive IVUS-guided stent implantation
did not create a further improvement in the hemodynamic
results. This suggests the presence of a plateau-phase of the
optimal hemodynamic response in relation to the residual
lumen obstruction, which can be achieved using IVUS-
guided balloon angioplasty. Preliminary results of the SIPS
(Strategy of ICUS guided PTCA and Stenting) trial dem-
onstrated a lower rate of target lesion revascularization at 6
months follow-up in patients treated with IVUS-guided
balloon angioplasty as compared with patients treated with
standard balloon angioplasty (43). In an observational study
Haase et al. also revealed clinical outcomes after IVUS-
guided balloon angioplasty similar to stent implantation
(14). Moreover, results of an ongoing clinical trial revealed
similar promising long-term outcomes regarding the target
lesion revascularization rate (7.8% vs. 12.9%; p 5 0.08) and
event-free survival (90% vs. 82%; p 5 0.05) after IVUS-
guided balloon angioplasty as compared with provisional
stent implantation (44).
In conjunction, the data from these clinical trials suggest
that IVUS-guided balloon angioplasty may serve as an
alternative for stent implantation resulting in a similar
clinical outcome.
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